243 related articles for article (PubMed ID: 35228057)
1. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
[TBL] [Abstract][Full Text] [Related]
2. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy.
Lo SY; Winston-McPherson GN; Starosta AJ; Sullivan MD; Baird GS; Hoofnagle AN; Greene DN
Am J Med; 2019 Mar; 132(3):347-353. PubMed ID: 30419224
[TBL] [Abstract][Full Text] [Related]
3. Drug use in Canadian patients with trauma after cannabis legalization.
Ball IM; Priestap F; Parry N; Pace J; Vogt KN
Can J Surg; 2021 Jul; 64(4):E403-E406. PubMed ID: 34296708
[TBL] [Abstract][Full Text] [Related]
4. Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization.
Tolan NV; Krasowski MD; Mathias PC; Wiencek JR; Babic N; Chai PR; Chambliss AB; Choucair I; Demetriou CA; Erickson TB; Feldhammer M; French D; Hayes BD; Kang P; El-Khoury JM; Knezevic CE; Monte A; Nerenz RD; Okorodudu AO; Roper SM; Saitman A; Thiriveedhi V; Uljon SN; Vest A; Woodworth A; Yu M; Melanson SEF
Clin Toxicol (Phila); 2023 Apr; 61(4):248-259. PubMed ID: 37129223
[TBL] [Abstract][Full Text] [Related]
5. Cannabis legalization and driving under the influence of cannabis and driving under the influence of alcohol among adult and adolescent drivers in Ontario, Canada (2001-2019).
Imtiaz S; Nigatu YT; Ali F; Agic B; Elton-Marshall T; Jiang H; Rehm J; Rueda S; Sanches M; Schwartz RM; Shield KD; Nibene Somé S; Sornpaisarn B; Wells S; Wickens CM; Hamilton HA
Drug Alcohol Depend; 2024 Feb; 255():111060. PubMed ID: 38181618
[TBL] [Abstract][Full Text] [Related]
6. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
Anderson KK; Rodrigues R; Le B; Mamun M; Archie S; Edwards J; Elton-Marshall T; Gilliland J; Myran DT; Palaniyappan L; Perlman CM; Seabrook JA; Murray RM; Shariff SZ
Int J Drug Policy; 2024 Jan; 123():104285. PubMed ID: 38071933
[TBL] [Abstract][Full Text] [Related]
8. Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective.
Bahji A; Socias ME; Bach P; Milloy MJ
Cannabis Cannabinoid Res; 2023 Oct; 8(5):699-702. PubMed ID: 37001172
[TBL] [Abstract][Full Text] [Related]
9. Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study.
Gali K; Winter SJ; Ahuja NJ; Frank E; Prochaska JJ
Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):16. PubMed ID: 33579324
[TBL] [Abstract][Full Text] [Related]
10. Treatment admissions for opioids, cocaine, and methamphetamines among adolescents and emerging adults after legalization of recreational marijuana.
Mennis J; Stahler GJ; Mason MJ
J Subst Abuse Treat; 2021 Mar; 122():108228. PubMed ID: 33509417
[TBL] [Abstract][Full Text] [Related]
11. The impact of recreational cannabinoid legalization on utilization in a pregnant population.
Torres J; Miller C; Apostol M; Gross J; Maxwell JR
Front Public Health; 2024; 12():1278834. PubMed ID: 38444440
[TBL] [Abstract][Full Text] [Related]
12. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
Shi Y; Liang D
Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
[TBL] [Abstract][Full Text] [Related]
13. Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue.
Kourgiantakis T; Vicknarajah R; Logan J; Edwards T; Lee E; Craig S; Kaura A; Williams CC; Marshall S
Subst Abuse Treat Prev Policy; 2024 Jun; 19(1):30. PubMed ID: 38886804
[TBL] [Abstract][Full Text] [Related]
14. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
15. The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review.
Allaf S; Lim JS; Buckley NA; Cairns R
Addiction; 2023 Dec; 118(12):2252-2274. PubMed ID: 37496145
[TBL] [Abstract][Full Text] [Related]
16. Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States.
Gunadi C; Zhu B; Shi Y
Addiction; 2022 Oct; 117(10):2651-2659. PubMed ID: 35618659
[TBL] [Abstract][Full Text] [Related]
17. Reefer madness or much ado about nothing? Cannabis legalization outcomes among young adults in the United States.
Parnes JE; Smith JK; Conner BT
Int J Drug Policy; 2018 Jun; 56():116-120. PubMed ID: 29626630
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada.
Rosic T; Sanger N; Panesar B; Foster G; Marsh DC; Rieb L; Thabane L; Worster A; Samaan Z
Subst Abuse Treat Prev Policy; 2021 Apr; 16(1):34. PubMed ID: 33849580
[TBL] [Abstract][Full Text] [Related]
19. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
Nguyen HV; McGinty EE; Mital S; Alexander GC
JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
[TBL] [Abstract][Full Text] [Related]
20. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
